No title
The integration of Artificial Intelligence (AI) into drug development introduces significant opportunities and ethical challenges, particularly with the use of complex "Black Box" AI systems. This study investigates how the drug development industry addresses ethical concerns associated with AI, focusing on compliance with European Union (EU) regulations, including the Assessment List fo
